A Study to Analyze Lung Transplant Recipients’ Perspective on Antifungal Prophylaxis

Overview

About this study

The purpose of this study is to explore adherence, barriers, side effects, and preference for pharmacologic antifungal prophylaxis following lung transplant. 

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Consenting individuals age 18 or older.
  • Have received a lung transplant within the last 36 months at Mayo Clinic Rochester MN or Mayo Clinic Jacksonville FL.
  • Have received or are receiving outpatient antifungal chemoprophylaxis. 

Exclusion Criteria

  • Under the age of 18 years old.
  • Multiple organ transplantations or re-transplantation.
  • Requires language interpreter.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Jacksonville, Fla.

Mayo Clinic principal investigator

Cassie Kennedy, M.D.

Open for enrollment

Contact information:

Karin Thompson

(800)753-1606

Thompson.Karin@mayo.edu

Rochester, Minn.

Mayo Clinic principal investigator

Cassie Kennedy, M.D.

Open for enrollment

Contact information:

Karin Thompson

(800)753-1606

Thompson.Karin@mayo.edu

More information

Publications

Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available

.
CLS-20502621

Mayo Clinic Footer